PubMed Health⌕ Search

Biomedical subjects

R Taurelle

Publications and source records attributed to R Taurelle.

At least 55 records · Page 3Linked to original sources

[Varicella in pregnancy].

Chickenpox rarely occurs during pregnancy but affected patients risk not only varicella pneumonia but also fetal contamination with potentially malformative effects or severe neonatal infection depending on whether the infection occurs early or late during pregnancy. More than 15% of the affected women have detectable lesions on the chest X-ray. Respiratory distress is the main risk with mortality reaching nearly 20%. Fetal contamination occurs via transplacental transmission. Fetal malformations are observed in less than 5% of the cases when fetal infection occurs early (before the end of the fifth month) but are generally quite severe. The mechanism is apparently fetal zona a few weeks after initial infection. Antenatal diagnosis is generally obtained on the basis of sonographic findings, and identification of viral genome using polymerase chain reaction on cordocentesis or amniotic fluid biopsy samples. Screening attempts to identify fetal anomalies and evaluate fetal prognosis. Induced abortion should be discussed in cases where both fetal malformation and fetal infection are confirmed. After five months, the risk of malformation appears to be much lower. It is known however that fetal varicella can be observed if the maternal infection occurs just before delivery. The most severe forms are seen when the maternal eruption occurs during the 4 days prior to delivery. Neonatal mortality in these cases reaches 20%. Unlike varicella, there is apparently little or no risk either for the mother or for the child in case of zona during pregnancy.

Chickenpox↗

[Use of anticoagulants during pregnancy].

Prolonged anticoagulant therapy may be indicated during pregnancy in patients with inborn diseases affecting haemostasis, mechanical heart valves, etc. A management scheme aimed at protecting both the mother and the foetus is presented on the basis of pharmacological data, the main series reported in the literature and the experience acquired at the Boucicaut hospital in Paris. Heparin should be used during the first trimester of pregnancy to avoid the teratogenic potential of antivitamin K drugs and to reduce the incidence of spontaneous abortions which increases in patients given oral anticoagulants. During the second and third trimester, antivitamin K drugs can be used more easily than heparin with no substantial increase in risk for the foetus. At delivery and during the immediate post partum period it is imperative to use a compound which does not cross the placental barrier (in order to avoid foetal hypocoagulation) and which has a short half-life. Heparin is therefore indicated again starting at eight months gestation. It is emphasized that despite careful management and follow-up by the co-ordinated efforts of cardiologists, obstetricians and the intensive care team haemorrhage occurs in 17% of the pregnant women given anticoagulants, particularly during the peri partum period.

4-Hydroxycoumarins↗

Does hormone replacement therapy increase the risk of breast cancer?

The data contained in the literature about breast cancer risk and hormone replacement therapy is reviewed. Many studies with different methodologies have been published. Analysis of classical papers or of meta-analysis do not support the view that short-term use of hormone replacement therapy significantly increases the risk of breast cancer. In some clinical situations such as family history of breast cancer, high dose estrogens and especially in the case of long term treatment over 10 years, risk of cancer could be increased and requires a specific clinical management. Despite of the absence of double blind placebo-controlled trial, there is no strong data available to oppose the use of estrogen replacement therapy because of an hypothetic increased risk of breast cancer. Using a low posology for less than 5 years in correctly managed women is a safe attitude.

Breast Neoplasms↗

Use of perioperative or split-course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer.

Treatment of local recurrence after conservative management for breast cancer is mastectomy. When mastectomy is contraindicated or refused, could brachytherapy be a therapeutic alternative for such isolated local relapses (ILR)? From February 1977 to June 1990, 38 patients, previously treated by radiation therapy or by a combination of radiotherapy and surgery for breast cancer, underwent salvage brachytherapy for an ILR. Fifteen patients were treated by limited tumorectomy plus 30 Gy perioperative brachytherapy for a 2.4-cm mean diameter IRL (Group A). Twenty-three patients were treated by exclusive split-course brachytherapy, delivering 60-70 Gy by two implants at 1-month interval, for a 3.9-cm mean diameter IRL (Group B). All patients achieved a clinical complete response after treatment. With a mean follow-up of 40 +/- 24 months, eight patients (21%) experienced local relapse between 9 and 48 months (four patients in Groups A and B). This second local recurrence was isolated in one case and was associated with metastatic disease in seven cases. At 5 years, overall survival was 55% (61% for Group A and and 50% for Group B). Three patients developed local complications requiring mastectomy (skin necrosis, two patients; severe breast pain, one patient). Cosmetic results in locally controlled patients were good in four patients, acceptable in twelve patients, mediocre in nine patients, and nonvaluable in two patients. Both perioperative brachytherapy and exclusive split-course brachytherapy appear to be feasible techniques and may be used occasionally as an alternative therapy to radical mastectomy for ILR.

Adult↗

[Recurrent tubal pregnancy after a intra-tubal injection of methotrexate. Analysis of an case report with a histological tubal study].

A second tubal pregnancy occurred in the same tube as the first one which had been treated with methotrexate injection. The hysterosalpingogram performed 3 months after the methotrexate injection was normal. The recurrent tubal pregnancy was treated by laparoscopic salpingectomy. The pathology report confirmed non-ruptured tubal pregnancy. No damage to the tube could be imputed to the methotrexate injection. This observation confirms that methotrexate has no deleterious effect on tubal epithelium but also emphasizes that recurrent ectopic pregnancy can occur despite a patent tube.

Adult↗

[Simultaneous radiochemotherapy in locally advanced cancers of the cervix: a preliminary study].

We have designed a combined treatment strategy of bifractionated split course radiotherapy (RT) and concomitant chemotherapy (CT) to try to improve the results of RT in inoperable cervical carcinoma. After evaluation, patients were submitted to further radical surgery or additional RT-CT depending on the treatment results. Between January 1988 and January 1992, 25 patients with non metastatic inoperable disease entered in the protocol. The stage of the disease was: T3N0 4 patients, T3 with hydronephrosis seven patients, T3N1 12 patients, and T4N0 two patients. Nineteen patients received two courses of CT with fluorouracil (F), cisplatin (P) with or without etoposide. Pelvic RT was given twice daily (two fractions of 3 Gy) on days 1, 3, 15 and 17. A combination of F 400 mg/m2/d and P 15 mg/m2/d in continuous infusion with oral etoposide (100 mg/d) and hydroxyurea (500 mg/d) in 11 patients was delivered concomitantly on days 1-3 and 14-17. A clinical and radiological evaluation was performed four weeks later. Patients with objective response underwent radical hysterectomy (group A) and those with incomplete response received additional RT-CT protocol (group B). All patients had endocavitary brachytherapy at the end of treatment. After two cycles of CT there were four PR in 19 patients and 5 failures. After RT-CT there were 12 CR (48%) and eight PR. There was a relationship between disease status after RT-CT and response to initial CT in those 19 patients who received the neoadjuvant CT. Fifteen patients were in group A, six of whom had no histologically active disease in the post-operative sample. However all 15 patients were rendered free of disease. Ten patients were in group B, five of whom attained the clinical CR status. In total, 20 of 25 patients (80%) were in CR at the end of treatment. Six patients experienced pelvic recurrence and two patients distant metastases. Four of the five patients with incomplete response had evolutive disease. The overall survival is 60% and 36% at 1 and 2 years respectively after a median follow-up of 22 months (14-48 m). The protocol was tolerable. These results compare favorably with those of conventional RT and warrant further evaluation.

Adult↗

[Cost effectiveness of methotrexate treatment of ectopic pregnancy].

OBJECTIVES: Compare the cost of managing unruptured extra-uterine pregnancy with methotrexate injections and with conservative laparoscopic surgery. METHODS: Review of the literature to quantify post-therapeutic follow-up after echoguided methotrexate injections or laparoscopic salpingotomy. The cost of each procedure was determined on the basis of the French National Health Insurance nomenclature (Caisse National d'Assurance-Maladie). Total costs thus induced were then compared. RESULTS: The cost of medical treatment for unruptured extra-uterine pregnancy was similar to laparoscopic surgical treatment (10,267 and 11,858 FFr respectively). The duration of hospitalization was short for methotrexate injection but the number of biology examinations required for post-therapeutic follow-up was greater. CONCLUSION: Cost of medical treatment and laparoscopic surgical treatment reported in the literature vary little. Ambulatory methotrexate injections and the major reduction in biology follow-up examinations are required for significant reduction in medical treatment costs. Rigorous patient selection for methotrexate treatment could both improve effectiveness and reduce costs. Eliminating anaesthesia-related mortality as well as any surgery would be the true beneficial effect of medical treatment.

Ambulatory Care↗

[Ethical problems with the current French practice in therapeutic abortions. Part 2: survey by questionnaire in 15 french university hospitals].

OBJECTIVE: Determine the circumstances and conditions concerning ethical problems raised by medical abortions treated in a certain number of University Hospitals. METHODS: Survey using a questionnaire during the first three months of 1993 in 15 gynaecology-obstetrics wards in University Hospitals in France. RESULTS: Fourteen responses were analysed. Usually with complementary open comments. CONCLUSION: Situations raising ethical problems concerning fetal medicine were encountered in approximately 5% of the pregnancies followed at the university Hospitals. Medical abortion was performed in 2% of the pregnancies. Gynaecologist-obstetricians prefer maintaining their control over prenatal diagnosis, especially when the outcome in medical abortion.

Abortion, Therapeutic↗

[Ethical problems with the current French practice in therapeutic abortions. Part 3: resolving moral dilemmas in fetal medicine].

OBJECTIVE: Based on the information acquired in the first two parts of this study and the data in the literature, to propose ethic codifications for solving moral dilemmas concerning fetal medicine. METHODS: Identification of situations where the object of the conflict is ethics: general methodology propositions for making individual decisions. RESULTS: In all cases a rigorous method is required, based on three main elements: a complete and well documented medical file; the opinion of the couple after appropriate participative communication; case by case collegial discussion. CONCLUSION: The methodology proposed underscores the roles played by health carers: obtain a medical file as complete as possible with prime emphasis on the infant; establish active communication with the parents giving greater value to their free examination of the situation; collegial discussion in order to be pertinent social partners.

Abortion, Therapeutic↗

[Congenital varicella. Problems with prenatal diagnosis after an early, primary maternal infection].

Chickenpox rarely occurs as a primary infection during pregnancy. There is a risk of foetal malformation only if the mother is infected before 20 weeks of gestation. The two main problems encountered for antenatal diagnosis of congenital varicella are the rare incidence of morphology anomalies (less than 35%) and the difficulty of establishing a functional prognosis. Echography is used to detect foetal malformations. In suspected cases the proof of viral infection can be based on results of foetal serology, viral culture or polymerase chain reactions. According to the literature, echographically detected malformations in cases with certain foetal infection have a poor outcome although conflicting cases have been reported.

Chickenpox↗

[Fetal echocardiography. The normal heart].

At 20 weeks amenorrhoea, it is currently possible to determine with echocardiography whether a fetal heart, which then weighs approximately 400g with a diameter of 15 mm, is normal or not. The incidence of cardiac malformations has been estimated at 8 per 1000 fetuses. Fetal factors including retarded growth, hydramnios and arrhythmia and maternal factors including rubeola, diabetes, systemic lupus erythematosus, Rhesus incompatibility and drugs increase fetal risk. In certain cardiopathies such as aortic stenosis, coarctation, malformation of the mitral valve or left ventricle hypoplasia, the risk of recurrence in a second fetus is greatly increased. With 2D echocardiography, the apical section of the four heart cavities orients the heart in the thorax, identifies the atria and ventricles and visualizes valve movement. The origin of the aorta and the kinetics of the mitral and aortic valves are studied on the para-sternal section. TM mode reproduces the P-QRS sequence thus allowing a measurement of heart rate, the thicknesses of heart walls and septa and identifies conduction disorders. The transvalvular systolic pressures can be measured with Doppler echocardiography and pulsed Doppler quantifies blood flow through the different heart structures. Precision can be increased with colour coding. A complete echocardiography of the fetal heart should be an integral part of all examinations of fetal morphology. Usually performed between 22 and 32 weeks of amenorrhoea, echocardiography of the fetal heart requires a perfect understanding of two-dimensional Doppler modes and of three-dimensional representation of heart anatomy.

Echocardiography↗

Varicella zoster virus infection during pregnancy: the limits of prenatal diagnosis.

In a mother with clinical evidence of chicken-pox at 12.5 weeks, fetal herpes varicella zoster infection was revealed by transient fetal ascites with liver calcifications at 27 weeks routine ultrasound. At 27 and 35 weeks fetal blood sampling and amniocentesis failed to demonstrate fetal viral infection. However, the diagnosis was confirmed postnatally based on thoracic herpes zoster at 8 months in an otherwise healthy infant. Polymerase chain reaction (PCR) on stored amniotic cells performed retrospectively was positive for varicella zoster virus (HVZV). This observation suggests that (1) in contrast to PCR, conventional fetal biology lacks sensitivity for prenatal diagnosis of HVZV infection, (2) the association of fetal sonographic abnormalities and positive amniotic PCR can be associated with a favorable pediatric outcome. Therefore, prenatal diagnosis of HVZV infection should be considered with the greatest caution.

Adult↗

[Surgical treatment of genito-urinary prolapses by abdominal approach. Results in a continuous series of 203 operations].

A series of 203 abdominal operations for correction of genital prolapse performed between 1985 and 1992 is reviewed. We performed abdominal sacral colpopexy systematically associated with a Burch retropubic uretropexy. Resection of the peritoneum of the pouch of Douglas, and myorraphy of the levator ani were performed according to the findings of the clinical examination. 94 patients underwent a sacral colpopexy using a single suture of the cervix to the promontory, 41 had an anterior mesh, 33 had a suture associated with an anterior mesh, and 35 had 2 meshes (anterior and posterior). 96% of the patients were between 41 and 65 years old, and 90% were perimenopausal. 78.6% were multiparous and 32% had a neonate weighting 4kg or more. Urinary stress incontinence was isolated in 38%, and associated with another disorder in 57.8%. Urodynamic studies revealed detrusor instability in 12.3% of patients, and sphincter incompetence in 15.2%. Urinary tract insection was the most frequent postoperative complication (61.5%). One month post-surgical evaluation showed good anatomic results in 94.2 to 100% of cases, and good functional results in 56 to 70.5%. The longterm results were anatomically good in 86.7 to 100% of the patients, and functionally good in 53.3 to 80.5% (mean follow-up = 32.5 months). Results were not significantly different between the 4 surgical procedures.

Adult↗

[Does hormone replacement therapy after menopause increase the risk of breast cancer?].

While the value of hormone replacement therapy appears now to be accepted, it is above all a prophylactic technique requiring evaluation of its benefit/risk ratio. The possible increased risk of breast cancer linked to this type of treatment remains a preoccupation which probably limits its more widespread use. The natural history of this cancer and inherent biases in the various types of study are such that analysis of the literature is often difficult and any definite conclusion is prevented. Certain trends nevertheless appear to emerge from the principal studies. While there is indeed an increased risk of onset of breast cancer, it is slight, other than with the use of high doses of estrogens for prolonged periods in women with a family history of breast cancer. Decreased overall mortality rate in women on replacement therapy and the improvement in their comfort tend to suggest that it is now legitimate to offer such treatment, provided its contra-indications are strictly observed and regular monitoring is ensured.

Breast Neoplasms↗

[Non-ruptured ectopic pregnancy. Treatment with methotrexate].

Methotrexate is now being used in the treatment of unruptured ectopic pregnancy. Experimental studies have shown that methotrexate inhibits the proliferation of normal trophoblast cells and that it has nos deleterious effect on tubal epithelium and no long-term teratogenic effect. Its pharmacokinetics is about the same when it is administered systemically or by intratubal injection. The clinical results obtained are independent of the mode of administration, with an 80 percent success rate. Thus, in the treatment of unruptured ectopic pregnancy methotrexate is a good alternative to laparoscopic surgery. The fertility of women treated with this drug seems to be preserved, but the published data are still insufficient and fragmentary.

Adult↗

[In defense of intra-uterine inseminations].

Intrauterine insemination (IUI) has been used for treatment of infertility for many years with discouraging results (8.3% in the analysis of Dorangeon and Quereux). A new approach of IUI, using ovarian stimulation, ovulation monitoring and sperm preparation has significantly improved the results. The obtained pregnancy rate (15 to 25%) are now comparable to those reported with IVF or GIFT. Therefore IUI should be offered to patients with patent tubes prior to their referral for the more invasive procedure FIV or GIFT.

Clinical Trials as Topic↗

[Anticoagulant treatment and pregnancy. Apropos of 47 cases].

The authors report a series of 47 patients treated with anticoagulants during pregnancy. The commonest indication was the presence of an artificial heart valve (72.3% of cases), most often mitral (58.9%). Thirty seven women were treated with heparin (group I) and ten with oral anticoagulants (OA) (group II) during the first three months. There was one peripheral venous thrombotic event and 2 post-partum deaths. Obstetric complications were equally distributed between the 2 groups, with the exception of spontaneous abortions during the first three months and fetal deaths, which were commoner with OA. Hemorrhagic complications occurred in 17% of cases at the time of delivery and during the immediate post-partum period. One case of coumarin embryopathy was seen. This series confirms that three periods are dangerous in the context of anticoagulant treatment during pregnancy: the first three months, delivery and postpartum. We recommend the use of heparin during the first three months and at the end of pregnancy, restricting OA to the period between 4 and 9 months.

4-Hydroxycoumarins↗